DK324888D0 - Substituerede staurosporinderivater - Google Patents

Substituerede staurosporinderivater

Info

Publication number
DK324888D0
DK324888D0 DK324888A DK324888A DK324888D0 DK 324888 D0 DK324888 D0 DK 324888D0 DK 324888 A DK324888 A DK 324888A DK 324888 A DK324888 A DK 324888A DK 324888 D0 DK324888 D0 DK 324888D0
Authority
DK
Denmark
Prior art keywords
substituted
staurosporin
formula
stau
staurosporin derivatives
Prior art date
Application number
DK324888A
Other languages
English (en)
Other versions
DK324888A (da
DK175507B1 (da
Inventor
Giorgio Caravatti
Andreas Fredenhagen
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK324888D0 publication Critical patent/DK324888D0/da
Publication of DK324888A publication Critical patent/DK324888A/da
Application granted granted Critical
Publication of DK175507B1 publication Critical patent/DK175507B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK198803248A 1987-06-15 1988-06-14 N-substituerede staurosporinderivater og salte deraf, fremgangsmåde til fremstilling deraf, farmaceutisk præparat med indhold deraf samt anvendelse af de N-substituerede staurosporinderivater til fremstilling af farmaceutiske præparater DK175507B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH224487 1987-06-15
CH224487 1987-06-15
CH144088 1988-04-19
CH144088 1988-04-19

Publications (3)

Publication Number Publication Date
DK324888D0 true DK324888D0 (da) 1988-06-14
DK324888A DK324888A (da) 1988-12-16
DK175507B1 DK175507B1 (da) 2004-11-15

Family

ID=25687663

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198803248A DK175507B1 (da) 1987-06-15 1988-06-14 N-substituerede staurosporinderivater og salte deraf, fremgangsmåde til fremstilling deraf, farmaceutisk præparat med indhold deraf samt anvendelse af de N-substituerede staurosporinderivater til fremstilling af farmaceutiske præparater

Country Status (20)

Country Link
EP (1) EP0296110B1 (da)
JP (1) JP2708047B2 (da)
KR (1) KR970001529B1 (da)
AT (1) ATE134375T1 (da)
AU (1) AU617324B2 (da)
CA (1) CA1337763C (da)
DE (1) DE3855015D1 (da)
DK (1) DK175507B1 (da)
ES (1) ES2083956T3 (da)
FI (1) FI89362C (da)
GR (1) GR3019064T3 (da)
HK (1) HK1003788A1 (da)
HU (1) HU201329B (da)
IE (1) IE70523B1 (da)
IL (1) IL86632A0 (da)
MY (1) MY104316A (da)
NO (1) NO170634C (da)
NZ (1) NZ225018A (da)
PT (1) PT87719B (da)
YU (1) YU115488A (da)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62220196A (ja) * 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd 新規物質ｕｃｎ―０１
JP2766360B2 (ja) * 1988-02-04 1998-06-18 協和醗酵工業株式会社 スタウロスポリン誘導体
IL89167A (en) * 1988-02-10 1994-02-27 Hoffmann La Roche Substituted pyrroles, their manufacture and pharmaceutical compositions containing them
USRE36736E (en) * 1989-02-06 2000-06-13 Hoffman-La Roche Inc. Substituted pyrroles
DE3924538A1 (de) * 1989-07-25 1991-01-31 Goedecke Ag Indolocarbazol und dessen verwendung
US5618809A (en) * 1989-12-14 1997-04-08 Schering Corporation Indolocarbazoles from saccharothrix aerocolonigenes copiosa subsp. nov SCC 1951 ATCC 53856
US5292747A (en) * 1990-08-07 1994-03-08 Hoffman-La Roche Inc. Substituted pyrroles
WO1993007153A1 (en) * 1991-10-10 1993-04-15 Schering Corporation 4'-(n-substituted-n-oxide)staurosporine derivatives
EP0541486A1 (de) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
WO1993018771A1 (fr) * 1992-03-24 1993-09-30 Asahi Kasei Kogyo Kabushiki Kaisha INHIBITEUR DE L'AGGLUTINATION PLAQUETTAIRE CONTENANT UN DERIVE DE STAUROSPORINE η-LACTAME
US5756494A (en) * 1992-07-24 1998-05-26 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
US5621100A (en) * 1992-07-24 1997-04-15 Cephalon, Inc. K-252a derivatives for treatment of neurological disorders
US5461146A (en) * 1992-07-24 1995-10-24 Cephalon, Inc. Selected protein kinase inhibitors for the treatment of neurological disorders
US5621101A (en) * 1992-07-24 1997-04-15 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
US5674867A (en) * 1992-09-21 1997-10-07 Kyowa Hakko Kogyo Co., Ltd. Indolocarbazole derivatives and therapeutic method for stimulating megakaicyocyte production
EP1447098A3 (en) 1993-01-28 2005-06-29 Boston Scientific Limited Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
PH30300A (en) * 1993-05-07 1997-01-20 Ciba Geigy Ag Polycyclic compounds and processes for the preparation thereof
WO1995002057A1 (en) * 1993-07-09 1995-01-19 The Institute Of Cancer Research Protein tyrosine kinase and ligands thereof
GB9325395D0 (en) * 1993-12-11 1994-02-16 Ciba Geigy Ag Compositions
EP0711557A1 (de) * 1994-11-09 1996-05-15 Ciba-Geigy Ag Pharmazeutische Formulierungsgrundlage
US6875865B1 (en) 1996-06-03 2005-04-05 Cephalon, Inc. Selected derivatives of K-252a
UA67725C2 (en) 1996-06-03 2004-07-15 Cephalon Inc K-252a derivatives and a method for improvement of functioning and cell survival enhancement
NZ333441A (en) 1996-06-25 1999-05-28 Cephalon Inc Use of k-252a derivatives for the treatment of peripheral or central nerve disorders, and cytokine overproduction
EP0975340B2 (en) 1997-03-31 2009-10-28 Boston Scientific Limited Therapeutic inhibitor of vascular smooth muscle cells
BR9915569A (pt) * 1998-11-23 2001-08-14 Novartis Ag Método para o tratamento de doenças neovasculares oculares
EP2762140B1 (en) 2001-02-19 2017-03-22 Novartis AG Treatment of solid brain tumours with a rapamycin derivative
CZ299756B6 (cs) 2001-05-16 2008-11-12 Novartis Ag Kombinace s obsahem N-{5-[4-(4-methyl-piperazino-methyl)benzoylamido]-2-methylfenyl}-4-(3-pyridyl)-2-pyrimidin-aminu k lécení proliferativních onemocnení
CN1582150B (zh) * 2001-10-30 2011-09-07 诺瓦提斯公司 作为flt3受体酪氨酸激酶活性抑制剂的星形孢菌素衍生物
US6887864B2 (en) 2002-03-12 2005-05-03 Hoffmann-La Roche Inc. Azepane derivatives
GB0206215D0 (en) 2002-03-15 2002-05-01 Novartis Ag Organic compounds
DK1505959T3 (da) 2002-05-16 2009-02-23 Novartis Ag Anvendelse af EDG-receptorbindingsmidler ved cancer
AU2003254566A1 (en) * 2002-07-23 2004-02-09 Novartis Ag Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
CA2524048C (en) 2003-05-19 2013-06-25 Irm Llc Immunosuppressant compounds and compositions
MY150088A (en) 2003-05-19 2013-11-29 Irm Llc Immunosuppressant compounds and compositions
US20040246627A1 (en) * 2003-06-06 2004-12-09 Durrum Thomas M. Disc drive pivot bearing assembly
CA2533861A1 (en) 2003-08-08 2005-02-17 Novartis Ag Combinations comprising staurosporines
TW200538433A (en) 2004-02-24 2005-12-01 Irm Llc Immunosuppressant compounds and compositiions
GB0512324D0 (en) 2005-06-16 2005-07-27 Novartis Ag Organic compounds
CN101010082A (zh) * 2004-08-31 2007-08-01 诺瓦提斯公司 米哚妥林用于治疗胃肠道基质瘤的用途
JO2897B1 (en) * 2004-11-05 2015-09-15 نوفارتيس ايه جي Organic compounds
US9006224B2 (en) 2005-11-21 2015-04-14 Novartis Ag Neuroendocrine tumor treatment
EP2379498B1 (en) 2008-12-18 2015-01-21 Novartis AG Polymorphic form of 1-(4-{1-[(e)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl}-2-ethyl-benzyl) -azetidine-3-carboxylic acid
JP2012512885A (ja) 2008-12-18 2012-06-07 ノバルティス アーゲー 新規な塩
AU2009335924B2 (en) 2008-12-18 2012-11-08 Novartis Ag Hemifumarate salt of 1- [4- [1- ( 4 -cyclohexyl-3 -trifluoromethyl-benzyloxyimino ) -ethyl] -2 -ethyl-benzyl] -a zetidine-3-carboxylic acid
EP2327706A1 (en) 2009-11-30 2011-06-01 Novartis AG Polymorphous forms III and IV of N-benzoyl-staurosporine
US8846712B2 (en) 2011-09-12 2014-09-30 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2847191B1 (en) 2012-05-09 2016-06-15 Sanofi Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors
WO2019215759A1 (en) * 2018-05-09 2019-11-14 Alaparthi Lakshmi Prasad An improved process for preparation of midostaurin
WO2021097256A1 (en) 2019-11-14 2021-05-20 Cohbar, Inc. Cxcr4 antagonist peptides
IT202000004291A1 (it) * 2020-03-02 2021-09-02 Indena Spa Processo per la purificazione di alcaloidi indolo carbazolici
CN112812129A (zh) * 2020-12-31 2021-05-18 浙江海正药业股份有限公司 米哚妥林的新晶型及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2766360B2 (ja) * 1988-02-04 1998-06-18 協和醗酵工業株式会社 スタウロスポリン誘導体

Also Published As

Publication number Publication date
HK1003788A1 (en) 1998-11-06
NZ225018A (en) 1990-09-26
NO882613L (no) 1988-12-16
MY104316A (en) 1994-03-31
PT87719B (pt) 1992-10-30
HUT47587A (en) 1989-03-28
DK324888A (da) 1988-12-16
HU201329B (en) 1990-10-28
IL86632A0 (en) 1988-11-30
JP2708047B2 (ja) 1998-02-04
KR890000494A (ko) 1989-03-15
ATE134375T1 (de) 1996-03-15
DE3855015D1 (de) 1996-03-28
FI882808A0 (fi) 1988-06-13
JPS6434989A (en) 1989-02-06
EP0296110A3 (de) 1991-02-27
FI89362C (fi) 1993-09-27
NO170634B (no) 1992-08-03
IE881787L (en) 1988-12-15
NO882613D0 (no) 1988-06-14
NO170634C (no) 1992-11-11
FI882808A (fi) 1988-12-16
AU617324B2 (en) 1991-11-28
KR970001529B1 (ko) 1997-02-11
AU1757188A (en) 1988-12-15
YU115488A (en) 1989-12-31
CA1337763C (en) 1995-12-19
PT87719A (pt) 1988-07-01
FI89362B (fi) 1993-06-15
IE70523B1 (en) 1996-12-11
EP0296110B1 (de) 1996-02-21
DK175507B1 (da) 2004-11-15
GR3019064T3 (en) 1996-05-31
ES2083956T3 (es) 1996-05-01
EP0296110A2 (de) 1988-12-21

Similar Documents

Publication Publication Date Title
DK324888D0 (da) Substituerede staurosporinderivater
ES2100907T3 (es) Bencimidazoles, medicamentos que contienen estos compuestos y proced imiento para su preparacion.
DK0584694T3 (da) Imidazolidin-derivater
RO86234A (ro) Procedeu pentru prepararea unor derivati de acilo0ipurine substituite
FR2482426B1 (fr) Procede de preparation d'un succedane de blanc d'oeuf a base de proteine de soja
SE8502017D0 (sv) 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same
MA22540A1 (fr) Diaminophtalimides substitues et derives analogues .
ES2086341T3 (es) Derivados de aminoacidos con propiedades inhibidoras de la renina, procedimiento para su preparacion, agentes que los contienen y su utilizacion.
FI890754A (fi) Kemiluminesoivia arkidiinijohdannaisia, niiden valmistus ja niiden käyttö luminesenssi-immuunimäärityksissä
MA19996A1 (fr) Procede de preparation de derives disubstitues de la proline
MA22251A1 (fr) Procede de preparation de derives de piperidine substitues en position 3
FR2627493B1 (fr) Procede de preparation de derives d'isoquinoleine
ES2038700T3 (es) Procedimiento para la obtencion de alilmercaptoacetil-sidnoniminas.
IT8420626A1 (it) "mezzi di dissuasione per uccelli"
ES503895A0 (es) Procedimiento para preparar 3b-hidroximetil-4a-hidroxi-8b- alcoxi-2,9-dioxatriciclo(4,3,1,03,7)decanos
MA22200A1 (fr) Procede de preparation de derives d'aminodiols
FR2659651B1 (fr) Procede de preparation de n-phenyl n'-(cyclo)alkyl paraphenylene diamines.
FR2572072B1 (fr) Procede de preparation de derives d'indole
FR2618781B2 (fr) Procede de preparation de derives de la 4,4-dimethyl tetrahydro pyr-2-one
FR2659650B1 (fr) Procede de preparation de n-phenyl n'-(cyclo)alkyl paraphnylene diamines.
RO92697A2 (ro) Procedeu pentru prepararea unor derivati de cumarina
FR2620449B1 (fr) Procede de preparation de derives de benzodiazepine-1,4 one-2

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHS Application shelved for other reasons than non-payment
PUP Patent expired